August 10, 2012 by Richard Monks and Chain Drug Review
American Express, credit card settlement, debit cards, Joseph Saunders, Mallory Duncan, MasterCard, National Retail Federation, NRF, swipe fees, Target Corp., Visa, Walmart
Issue 08-13-2012, News
NEW YORK — After credit card companies and some of the nation’s largest banks agreed to pay more than $7 billion to settle a price-fixing case dealing with swipe fees, the future of the deal was put in jeopardy when several retailers objected to the terms of the pact. The settlement must still be approved
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
WASHINGTON — Trade associations representing thousands of retailers have thrown their support behind proposed federal legislation that would require online merchants and other remote sellers to collect sales tax. The National Association of Chain Drug Stores, the National Retail Federation (NRF) and the Retail Industry Leaders Association all say the Marketplace Fairness Act that was
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
CHICAGO — Walgreen Co. has launched a pilot program that will allow patients to make appointments at some of the retailer’s Take Care Clinics via their smartphones. The iTriage mobile application, available for iPhones and Android phones, is designed to help consumers identify symptoms, learn more about medical conditions and access a nationwide directory of
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
NEW YORK — Duane Reade, which has purchased 14 electric trucks in a bid to reduce the air and noise pollution associated with store deliveries, is asking its customers where they should be deployed. The new electric vehicles will replace nearly 25% of the retailer’s truck fleet. To determine which stores should be among the
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
WATERBURY, Conn. — For most of her 62 years, Deborah Klein has lived a relatively comfortable life. She raised two children, held down a career and considered herself a productive member of society. But in 2005, her fortunes began to change. She was laid off from her $80,000-a-year job but managed to find a series
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, News
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, Opinion
It’s been an interesting summer for chain drug retailing. Here, in no particular order, are the season’s most interesting events: • Walgreens merged — if that’s the appropriate word — with Alliance Boots by acquiring a 45% interest in the world’s leading drug retailer/wholesaler. The word “leading” needs to be explained here. It is not
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, Opinion
It has been said that improved medication adherence is the next blockbuster. That insight has motivated pharmacy operators, drug makers and pharmaceutical distributors, among others, to tackle the problem. Recent work by three drug chains — industry leaders CVS Caremark and Walgreens, and Thrifty White, which operates 87 stores in six states in the Midwest
August 10, 2012 by Chain Drug Review
Issue 08-13-2012, Opinion
Known variably as sexual health, sexual well-being and family planning, the sexual wellness category is intertwined with social and cultural trends. Although both male and female contraceptives are staples of the product assortment, the continued arrival of more personal intimacy and enhancement items compels the category’s boundaries to evolve. Influencing this evolution is the convenient
August 9, 2012 by Chain Drug Review
Supplier News
PRINCETON, N.J. — Bristol-Myers Squibb Co. has completed its acquisition of Amylin Pharmaceuticals Inc. Under the deal announced early last month, Bristol-Myers agreed to buy Amylin for $31 per share in cash, pursuant to a cash tender offer and second-step merger, for an aggregate purchase price of about $5.3 billion. The total value of the
August 9, 2012 by Chain Drug Review
Supplier News
ALLEGAN, Mich. — Perrigo Co. has received final approval from the Food and Drug Administration for its abbreviated new drug application (ANDA) for morphine sulfate 100ml/5% oral solution. The company said Wednesday that it will start shipping the product, a narcotic pain medication, immediately. Morphine sulfate oral solution is a Schedule II controlled substance, indicated
August 9, 2012 by Chain Drug Review
Retail News
SEATTLE — This fall, Bartell Drugs plans to relocate its corporate headquarters to West Seattle. The Puget Sound-area drug chain said that in October it expects to move from its location on Denver Avenue South in the Georgetown industrial area south of downtown Seattle to the West Seattle Corporate Center at Delridge Way Southwest. Bartell’s
August 9, 2012 by Chain Drug Review
Retail News
TORONTO — Shoppers Drug Mart Corp. next week plans to launch an online portal to help mark its 50th anniversary in September. The Canadian drug chain said Thursday that on Aug. 13 it will go live with the interactive "50 Fabulous Years" digital hub, which will enable customers to "share the moments when Shoppers Drug